LIVENPHARMACEUTICALSLatest resultJun-26
Liven Pharma Limited
Shariah compliantReturn on equity-3%
Alpha score••members only
Last close
−3.66%Rs30
3 monthsAs of 5 Oct
AlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, LIVEN's sales rose 103% to Rs 13.2mn, from Rs 6.5mn, and profit after tax was a loss of Rs 25.2mn, against a loss of Rs 695.3mn (compared with Apr–Jun 2025).
Earnings per share were -Rs 0.23, against -Rs 10.76 a year earlier.
- Dividend payout
- 0%
- of earnings
- Return on equity
- -3%
- Net margin
- -29.0%
- trailing twelve months
- Debt to equity
- 0.03
LIVEN quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 13.2mn | -Rs 25.2mn | -191.5% | -Rs 0.23 | — |
| Jan–Mar 2026 | Rs 29.2mn | -Rs 4.0mn | -13.5% | -Rs 0.03 | — |
| Oct–Dec 2025 | Rs 54.6mn | Rs 28.2mn | 51.7% | Rs 0.30 | — |
| Jul–Sep 2025 | Rs 8.8mn | -Rs 30.2mn | -341.9% | -Rs 0.32 | — |
| Apr–Jun 2025 | Rs 6.5mn | -Rs 695.3mn | -10727.4% | -Rs 10.76 | — |
| Jan–Mar 2025 | Rs 14.8mn | -Rs 9.6mn | -65.2% | -Rs 0.13 | — |
| Oct–Dec 2024 | Rs 17.1mn | -Rs 9.5mn | -55.4% | -Rs 0.20 | — |
| Jul–Sep 2024 | Rs 88.9mn | Rs 128.7mn | 144.8% | Rs 2.66 | — |
LIVEN annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 105.8mn | -Rs 31.1mn | -Rs 0.28 | — |
| Year to Jun 2025 | Rs 127.3mn | -Rs 585.7mn | -Rs 8.44 | — |
| Year to Jun 2024 | — | Rs 41.7mn | Rs 3.44 | — |
| Year to Jun 2023 | — | -Rs 12.3mn | -Rs 1.02 | — |
| Year to Jun 2022 | — | -Rs 14.3mn | -Rs 1.18 | — |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 1.2bn
- Shareholders' equity
- Rs 985.5mn
- Cash & bank
- Rs 18.3mn
- Total debt
- Rs 33.4mn
- Current ratio
- 2.63
- 3-month high
- Rs 40.72
- 3-month low
- Rs 30.00
- 1-month change
- -9.4%
- 3-month change
- -25.7%
Read more about LIVEN
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
LIVEN: common questions
What is LIVEN's share price?
Liven Pharma Limited (LIVEN) last closed at Rs 30.00 on the Pakistan Stock Exchange.
Does LIVEN pay a dividend?
Liven Pharma Limited reported no dividend for the year to Jun 2026.
What were LIVEN's latest results?
In the Apr–Jun 2026 quarter, LIVEN's sales rose 103% to Rs 13.2mn, from Rs 6.5mn, and profit after tax was a loss of Rs 25.2mn, against a loss of Rs 695.3mn (compared with Apr–Jun 2025).
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.